p40 Immunohistochemistry Is an Excellent Marker in Primary Lung Squamous Cell Carcinoma

Background Lung cancer is the third most common cancer worldwide. With major advances in the molecular testing of lung cancers and the introduction of targeted therapies, the distinction between adenocarcinoma and squamous cell carcinoma as well as pathologic subtyping has become important. Recent s...

Full description

Saved in:
Bibliographic Details
Main Authors: Khairunisa Ahmad Affandi (Author), Nur Maya Sabrina Tizen (Author), Muaatamarulain Mustangin (Author), Reena Rahayu MdReena Rahayu Md Zin (Author)
Format: Book
Published: Korean Society of Pathologists & the Korean Society for Cytopathology, 2018-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_4cd93fc8df994b7d8767024cdfd0cf1a
042 |a dc 
100 1 0 |a Khairunisa Ahmad Affandi  |e author 
700 1 0 |a Nur Maya Sabrina Tizen  |e author 
700 1 0 |a Muaatamarulain Mustangin  |e author 
700 1 0 |a Reena Rahayu MdReena Rahayu Md Zin  |e author 
245 0 0 |a p40 Immunohistochemistry Is an Excellent Marker in Primary Lung Squamous Cell Carcinoma 
260 |b Korean Society of Pathologists & the Korean Society for Cytopathology,   |c 2018-09-01T00:00:00Z. 
500 |a 2383-7837 
500 |a 2383-7845 
500 |a 10.4132/jptm.2018.08.14 
520 |a Background Lung cancer is the third most common cancer worldwide. With major advances in the molecular testing of lung cancers and the introduction of targeted therapies, the distinction between adenocarcinoma and squamous cell carcinoma as well as pathologic subtyping has become important. Recent studies showed that p40 is highly specific for squamous and basal cells and is superior to p63 for diagnosing lung squamous cell carcinoma. The aim of this study was to evaluate the use of p40 immunohistochemical stain in the diagnosis of non-small cell lung carcinoma and its potential to replace current p63 antibody as the best immunohistochemical squamous marker. Methods Seventy formalin-fixed paraffin-embedded cases previously diagnosed as primary lung squamous cell carcinoma (n = 35) and lung adenocarcinoma (n = 35) from January 2008 to December 2016 were retrieved. The results of tumour cell immunoreactivity for p40 and p63 antibodies in lung squamous cell carcinoma and lung adenocarcinoma were compared. Results p40 was expressed in 27 cases of lung squamous cell carcinoma (77.1%). All cases of lung adenocarcinoma (35/35, 100%) were negative for p40. p63 expression was positive in 30 cases of lung squamous cell carcinoma (85.7%) and 13 cases of lung adenocarcinoma (37.1%). Reactivity for both p40 and p63 in lung squamous cell carcinoma was strong and diffuse, whereas variable reactivity was observed in lung adenocarcinoma. Conclusions p40 is an excellent marker for distinguishing lung squamous cell carcinoma from adenocarcinoma, and p40 expression is equivalent to p63 expression in lung squamous cell carcinoma. 
546 |a EN 
546 |a KO 
690 |a Non-small cell lung carcinoma 
690 |a Immunohistochemistry 
690 |a Lung neoplasms 
690 |a p40 
690 |a p63 
690 |a Pathology 
690 |a RB1-214 
655 7 |a article  |2 local 
786 0 |n Journal of Pathology and Translational Medicine, Vol 52, Iss 5, Pp 283-289 (2018) 
787 0 |n http://www.jpatholtm.org/upload/pdf/jptm-2018-08-14.pdf 
787 0 |n https://doaj.org/toc/2383-7837 
787 0 |n https://doaj.org/toc/2383-7845 
856 4 1 |u https://doaj.org/article/4cd93fc8df994b7d8767024cdfd0cf1a  |z Connect to this object online.